| Literature DB >> 19574693 |
Pramod Bhende1, Lingam Gopal, Tarun Sharma, Aditya Verma, Rupak Kanti Biswas.
Abstract
BACKGROUND: While lens-sacrificing vitrectomy is the standard approach to manage Stage 5 retinopathy of prematurity (ROP), scleral buckling has been used to manage some cases of Stage 4. Lens-sparing vitrectomy was popularized by Maguire and Trese in selected cases of Stage 4 disease.Entities:
Mesh:
Year: 2009 PMID: 19574693 PMCID: PMC2712694 DOI: 10.4103/0301-4738.53050
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 1.848
General patient data: 39 eyes of 31 patients
| Eye | Sex | BW | GA | PCA | AP | AS | MC | Eye | ROP | VH | PH | TRD | IOC | RS2 | RSL | Vn |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 1000 | 28 | 39 | 39 | 39 | 2,6 | OS | 4b | N | N | 7 | 0 | 3 | 3 | 2 |
| 2 | M | 1200 | 27 | 37 | 33 | 37 | 6 | OS | 4a | N | N | 4 | 1 | 1 | 2 | 1 |
| 3 | M | 900 | 26 | 41 | 36 | 41 | 3,6 | OD | 4a | N | Y | 1 | 1 | 2 | 1 | 1 |
| 4 | M | 1070 | 29 | 38 | 33 | 38 | 1,3,6 | OS | 4a | N | N | 2 | 0 | 1 | 1 | 2 |
| 5 | F | 2040 | 34 | 48 | 46 | 48 | 3 | OD | 4b | N | N | 7 | 0 | 3 | 3 | 2 |
| 6 | M | 1510 | 31 | 42 | 37 | 42 | 3,6 | OS | 4b | N | N | 7 | 1 | 2 | 2 | 1 |
| 7 | M | 1320 | 30 | 44 | 37 | 44 | 1,3,6 | OD | 4b | N | N | 6 | 1 | 1 | 1 | 1 |
| 8 | M | 1080 | 28 | 45 | 36 | 45 | 1,3,6 | OS | 4a | N | N | 4 | 1 | 4 | 5 | 2 |
| 9 | M | 1080 | 28 | 47 | 36 | 47 | 1,3,6 | OD | 4a | N | N | 4 | 2 | 4 | 5 | 2 |
| 10 | M | 2250 | 32 | 41 | 39 | 41 | 2,3,6 | OD | 4b | N | Y | 7 | 2 | 4 | 6 | 2 |
| 11 | F | 1100 | 28 | 40 | 33 | 40 | 2,6 | OS | 4a | N | N | 3 | 0 | 1 | 1 | 1 |
| 12 | M | 750 | 25 | 42 | 42 | 42 | 1,3,6 | OD | 4a | N | N | 1 | 0 | 1 | 1 | 1 |
| 13 | M | 750 | 25 | 43 | 42 | 43 | 1,3,6 | OS | 4a | N | N | 1 | 0 | 1 | 1 | 1 |
| 14 | M | 1075 | 28 | 43 | 39 | 43 | 1,2,3 | OS | 4b | N | N | 7 | 1 | 3 | 3 | 2 |
| 15 | M | 1110 | 28 | 42 | 34 | 42 | 1,3,6 | OS | 4a | N | Y | 2 | 1 | 2 | 1 | 1 |
| 16 | F | 1600 | 30 | 46 | 44 | 46 | 3 | OD | 4a | N | N | 4 | 0 | 2 | 1 | 1 |
| 17 | F | 960 | 28 | 36 | 33 | 36 | 2,3 | OS | 4a | Y | N | 3 | 1 | 1 | 1 | 1 |
| 18 | M | 1040 | 28 | 44 | 43 | 44 | 2,3 | OS | 4a | N | N | 1 | 0 | LTF | LTF | |
| 19 | M | 950 | 27 | 57 | 52 | 57 | 3,6 | OD | 4a | N | N | 1 | 0 | 2 | 2 | 1 |
| 20 | F | 1270 | 30 | 43 | 36 | 43 | 2,3 | OD | 4a | N | Y | 3 | 0 | 2 | 1 | 2 |
| 21 | F | 1350 | 30 | 42 | 38 | 42 | 1,3 | OD | 4a | Y | Y | 5 | 1 | 1 | 1 | 1 |
| 22 | F | 1350 | 30 | 44 | 38 | 44 | 1,3 | OS | 4a | Y | Y | 5 | 0 | 1 | 1 | 1 |
| 23 | M | 1500 | 32 | 41 | 37 | 41 | 1,2,3 | OD | 4b | N | N | 7 | 3 | 3 | 3 | 2 |
| 24 | M | 1500 | 32 | 42 | 37 | 42 | 1,2,3 | OS | 4b | N | N | 7 | 3 | 1 | 1 | 1 |
| 25 | M | 1550 | 30 | 44 | 34 | 44 | 1,2 | OS | 4b | N | N | 6 | 0 | 2 | 1 | 1 |
| 26 | M | 1500 | 34 | 41 | 38 | 41 | 2,3 | OD | 4a | N | N | 2 | 1 | 5 | 6 | 2 |
| 27 | M | 1232 | 31 | 42 | 40 | 42 | 2,3 | OD | 4a | N | N | 4 | 0 | 2 | 2 | 1 |
| 28 | M | 1232 | 31 | 43 | 40 | 43 | 2,3 | OS | 4a | N | Y | 4 | 0 | 2 | 2 | 1 |
| 29 | M | 1335 | 26 | 41 | 40 | 41 | 3,6 | OD | 4b | N | N | 1,7 | 0 | 2 | 1 | 2 |
| 30 | F | 650 | 24 | 38 | 36 | 38 | 1,3,6 | OS | 4a | N | N | 2 | 0 | 1 | 1 | 1 |
| 31 | F | 650 | 24 | 39 | 36 | 39 | 1,3,6 | OD | 4a | N | N | 2 | 0 | 1 | 1 | 2 |
| 32 | F | 1000 | 27 | 40 | 32 | 40 | 2,3,6 | OS | 4a | N | N | 3 | 3 | 1 | 1 | 1 |
| 33 | F | 1200 | 30 | 42 | 34 | 42 | 1,2,3,6 | OS | 4a | N | N | 5 | 1 | 1 | 1 | 1 |
| 34 | F | 1200 | 30 | 45 | 34 | 45 | 1,2,3,6 | OD | 4a | N | N | 5 | 0 | 1 | 1 | 1 |
| 35 | M | 1350 | 30 | 39 | 38 | 39 | 1,2,3,6 | OD | 4a | N | N | 3 | 0 | 6 | 1 | 1 |
| 36 | M | 1350 | 30 | 40 | 38 | 40 | 1,2,3,6 | OS | 4a | N | Y | 3 | 0 | 2 | 2 | 1 |
| 37 | M | 1500 | 30 | 44 | 34 | 44 | 2,3 | OS | 4a | N | N | 5 | 4 | 3 | 4 | 2 |
| 38 | M | 1970 | 32 | 43 | 38 | 43 | 2,3,6 | OD | 4a | N | N | 1 | 0 | 1 | 1 | 1 |
| 39 | F | 970 | 26 | 42 | 41 | 42 | 1,2,3,6 | OS | 4a | N | N | 1 | 0 | 3,6 | 5 | 2 |
No = Serial number (number of patient); Eye = Number of eye; Sex = F (Female), M (Male); BW = Birth weight in grams; GA = Gestational age in weeks; AP = Age at presentation in weeks (post-conceptual); AS = Age at surgery in weeks (post-conceptual); MC = Medical condition at birth (from NICU records) 1 = Septicemia, 2 = Hyperbilirubinemia, 3 = Respiratory distress syndrome, 4 = Hyperglycemia, 5 = Hypoglycemia, 6 = Others; Eye = OD (Right eye), OS (Left eye); ROP = Stage of retinopathy of prematurity at surgery (4a or 4b); PH = Preretinal hemorrhage preoperatively (Y = Present, N = Absent); VH = Vitreous hemorrhage preoperatively (Y = Present, N = Absent); TRD = Location of fractional retinal detachment (1 = Temporal, 2 = Nasal, 3 = Superior, 4 = Inferior, 5 = Peri-papillary, 6 = Macular drag, 7 = Posterior pole); LTF = Lost to follow-up; IOC: Intraoperative complications (0 = No complications, 1 = Minimal bleeding, 2 = Moderate to severe bleeding hampering completion of surgery, 3 = Retinal break, 4 = Corneal clouding). RS2 = Retinal status at two months follow-up (1 = Attached totally, 2 = Attached posterior pole, 3 = Detached posterior pole, 4 = Total RD, 5 = Closed funnel RD, 6 = Diffuse Vitreous hemorrhage); RSL = Retinal status at last follow-up visit (1 = Attached totally, 2 = Attached posterior pole, 3 = Detached posterior pole, 4 = Total RD, 5 = Closed funnel RD, 6 = Diffuse Vitreous hemorrhage); Vn = Vision at the last follow-up visit (1 = Central, Steady, Maintained; 2 = Not Following Light 3 = Not assessed)
Demographic data and surgical outcome
| Profile | Total | Stage 4a | Stage 4b |
|---|---|---|---|
| Number of eyes/Number of patients | 39/31 | 29/23 | 10/8 |
| Gender | |||
| Males | 25 eyes | 17 eyes | 8 eyes |
| Females | 14 eyes | 12 eyes | 2 eyes |
| Mean gestatlonal age (weeks)/range | 29 wks/24-34 wks | 28.5 wks/24-34 wks | 30.3 wks/26-34 wks |
| Mean birth weight (grams)/range | 1242 g/650-2250g | 1150.5 g/650-1970g | 1 508 g/1 000-2250 g |
| Age at presentation (weeks)/range | 37.6 wks/32-52 wks | 35.7 wks/32-52 wks | 38.5 wks/34-46 wks |
| Age at surgery (weeks)/range | 42 wks/36-57 wks | 42.2 wks/36-57 wks | 42.5 wks/39-48 wks |
| Follow-up (months)/range | 15 mth/2-55mth | 13.6 mth/2-55mth | 18.6 mth/5-48mth |
| Preoperative status | |||
| Rubeosis (%) | 6 (15) | 6 (20) | 0 |
| Vitreous hemorrhage + Preretinal hemorrhage (%) | 2 (5) | 2 (7) | 0 |
| Relatively florid neovascularization (%) | 9 (23) | 7 (24) | 2 |
| Preoperative retinal ablation (%) | 34 (87) | 26 (90) | 7 |
| Adequate relief of traction (%) | 37 (95) | 27 (93) | 9 |
| latrogenic breaks (%) | 3 (8) | 1 (3) | 2 |
| Postoperative status | (n = 38) | (n = 28) | (n = 10) |
| Anatomic success (one procedure) (%) | 28 (74) | 23 (82) | 5 |
| Anatomic success (final) (%) | 34 (89) | 27 (96) | 7 |
| Favorable vision (one procedure) (%) | 24 (63) | 20 (71) | 4 |
| Favorable vision (final) (%) | 30 (79) | 24 (86) | 6 |
Figure 1(a) Preoperative fundus photograph showing fibrovascular proliferation (FVP) and focal tractional detachment involving posterior pole (arrow). Note the well-ablated peripheral retina (b) Corresponding postoperative fundus photo of the same patient. Note the trimmed FVP at the disc with radiating dry retinal folds (arrow)